ZALSENERTANT TETRAXETAN
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 1613265-38-5 |
|---|---|
| INCI Name | 2-[[5-(2,6-dimethoxyphenyl)-1-[4-[methyl-[3-[methyl-[3-[methyl-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propyl]amino]propyl]carbamoyl]-2-propan-2-ylphenyl]pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid |
| PubChem CID | 74766516 |
| Molecular Formula | C58H84N10O13 |
| InChIKey | InChI=1S/C58H84N10O13/c1-38 |
| SMILES | CC(C)C1=C(C=CC(=C1)C(=O)N(C)CCCN(C)CCCN(C)C(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)N3C(=CC(=N3)C(=O)NC4(C5CC6CC(C5)CC4C6)C(=O)O)C7=C(C=CC=C7OC)OC |
Known Aliases (3)
Common Name
zalsenertant tetraxetan [INN]
Scientific Name
10-[2-[[3-[[3-[[4-[3-[[(2-Carboxytricyclo[3.3.1.13,7]dec-2-yl)amino]carbonyl]-5-(2,6-dimethoxyphenyl)-1H-pyrazol-1-yl]-3-(1-methylethyl)benzoyl]methylamino]propyl]methylamino]propyl]methylamino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[3-[[3-[[4-[3-[[(2-carboxytricyclo[3.3.1.13,7]dec-2-yl)amino]carbonyl]-5-(2,6-dimethoxyphenyl)-1H-pyrazol-1-yl]-3-(1-methylethyl)benzoyl]methylamino]propyl]methylamino]propyl]methylamino]-2-oxoethyl]-
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | XF82V61Y8U |
ZALSENERTANT TETRAXETAN |
CAS: 1613265-38-5 INN: 11446 SMS_ID: 300000038100 PUBCHEM: 74766516 FDA UNII: XF82V61Y8U NCI_THESAURUS: C175878 |
Record Info
| ID | Qno8zpsQsLqBRbxaD484oz |
|---|---|
| Created | April 10, 2026, 11:04 p.m. |
| Modified | April 10, 2026, 11:07 p.m. |
| Enriched | April 11, 2026, 12:09 a.m. |
| Data Source | FDA Substance Registry (openFDA) |